Fig. 1From: Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective studya The platelet counts after lusutrombopag treatment in all patients (left panel, n = 31), group A (middle panel, n = 23), and group B (right panel, n = 8). b The platelet count in patients who received platelet transfusion after lusutrombopag treatment (n = 7). **p < 0.01, n.s not significant, LUS lusutrombopag, PTF platelet transfusionBack to article page